SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001062993-17-002116
Filing Date
2017-04-28
Accepted
2017-04-28 15:52:10
Documents
1
Group Members
PELICAN PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g_balk.htm SC 13G 41317
  Complete submission text file 0001062993-17-002116.txt   42664
Mailing Address 229 WEST 60TH STREET NEW YORK NY 10023
Business Address
BALK MATTHEW (Filed by) CIK: 0001217674 (see all company filings)

Type: SC 13G

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89966 | Film No.: 17795206
SIC: 2834 Pharmaceutical Preparations